Company Profile
Revelation Biosciences Stock Price, News & Analysis
- Ticker:
- REVB
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
1.12 USD (-2.61%)
Close
Last updated: August 6, 2026
4.14M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, REVB closed down 2.61% at $1.12. No new same-company headline was identified in the current news window.
Company overview
Business overview
Revelation Biosciences is a biotechnology company focused on innate immunity and inflammation-linked disease biology. Its story centers on using immune modulation to address difficult inflammatory conditions.
Geographic Base and Sector Classification
Revelation is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with an immunology focus.
Business Model Characteristics
The company depends on early clinical and preclinical progress, capital efficiency, and the ability to show that its platform can create differentiated value. Investors watch proof-of-concept data and financing runway.
Position Within the Biotechnology Landscape
Revelation occupies a speculative immune-modulation niche within biotech. It is a small company where data quality and strategic focus dominate the stock.
Future catalysts
Revelation’s catalysts are microbiome / inflammation programs and any update that shows the platform can still progress clinically. The company remains highly dependent on data.
Recent news
- 01
- 02
Revelation Biosciences Inc. Announces Closing of $5 Million Public Offering
Source: Revelation Biosciences
- 03
Revelation Biosciences Inc. Announces Pricing of $5 Million Public Offering
Source: Revelation Biosciences
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Revelation Biosciences (REVB)?
Revelation Biosciences (REVB) most recently closed at 1.12 USD, a -2.61% move versus the previous session.
What is the market cap of Revelation Biosciences (REVB)?
Revelation Biosciences currently has a market capitalization of 4.14M USD on BioPharmSignal.
What does Revelation Biosciences do?
Revelation Biosciences is a biotechnology company focused on innate immunity and inflammation-linked disease biology. Its story centers on using immune modulation to address difficult inflammatory conditions.
On which exchange is REVB stock listed?
Revelation Biosciences (REVB) is associated with NASDAQ, United States, MedTech.
What is Revelation?
Revelation’s catalysts are microbiome / inflammation programs and any update that shows the platform can still progress clinically.
Which conditions is Revelation Biosciences targeting with Revelation?
Revelation Biosciences is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does Revelation Biosciences describe recent progress with Revelation?
Revelation’s catalysts are microbiome / inflammation programs and any update that shows the platform can still progress clinically.
What is Biosciences?
Revelation Biosciences is a biotechnology company focused on innate immunity and inflammation-linked disease biology.